In gastric cancer, high TRPV2 expression correlates with advanced stage and poor prognosis, and mechanistically, TRPV2 confers cisplatin resistance by modulating cisplatin-induced apoptosis [175]. The gene discussed is TRPV2; the disease is gastric cancer.